These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19110706)

  • 21. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

  • 22. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend.
    Peters AL; Davidson MB
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2423-7. PubMed ID: 8675555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetes mellitus in dogs: relationship of obesity to glucose tolerance and insulin response.
    Mattheeuws D; Rottiers R; Kaneko JJ; Vermeulen A
    Am J Vet Res; 1984 Jan; 45(1):98-103. PubMed ID: 6367563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes mellitus with pancreatic beta cell dysfunction in 3 horses confirmed with minimal model analysis.
    Durham AE; Hughes KJ; Cottle HJ; Rendle DI; Boston RC
    Equine Vet J; 2009 Dec; 41(9):924-9. PubMed ID: 20383993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Type 1 diabetes mellitus: pathogenesis, symptoms and therapy].
    Gero L
    Orv Hetil; 2010 Mar; 151(13):533-9. PubMed ID: 20304746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy.
    Sönksen PH; Lowy C; Perkins JR; Lim HS
    Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glargine insulin and high-protein-low-carbohydrate diet in cats with diabetes mellitus.
    Boari A; Aste G; Rocconi F; Dalessandri A; Vita S
    Vet Res Commun; 2008 Sep; 32 Suppl 1():S243-5. PubMed ID: 18685984
    [No Abstract]   [Full Text] [Related]  

  • 30. [Indications for a favourable effect of intensive insulin therapy for newly-diagnosed type 2 diabetes].
    Roep BO; Pijl H
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2378-80. PubMed ID: 19055134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
    Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes mellitus in nonhuman primates: recent research advances and current husbandry practices.
    Howard CF; Yasuda M
    J Med Primatol; 1990; 19(7):609-25. PubMed ID: 2254913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overweight and increased diabetes susceptibility in neonatally insulin-treated adult rats.
    Harder T; Rake A; Rohde W; Doerner G; Plagemann A
    Endocr Regul; 1999 Mar; 33(1):25-31. PubMed ID: 10200585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidiabetic effect of Symplocos cochinchinensis (Lour.) S. Moore. in type 2 diabetic rats.
    Sunil C; Ignacimuthu S; Agastian P
    J Ethnopharmacol; 2011 Mar; 134(2):298-304. PubMed ID: 21182925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prevention of diabetes mellitus by prevention of obesity in monkeys.
    Hansen BC; Bodkin NL
    Diabetes; 1993 Dec; 42(12):1809-14. PubMed ID: 8243827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential diagnosis of insulin- and noninsulin-dependent diabetes mellitus--are there therapeutic implications?].
    Tappy L; Fröhlich FE
    Praxis (Bern 1994); 1994 Dec; 83(50):1406-9. PubMed ID: 7801016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Considerations regarding the diagnosis and treatment of childhood type 2 diabetes.
    Zeitler P
    Postgrad Med; 2010 May; 122(3):89-97. PubMed ID: 20463418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.
    Levy J; Atkinson AB; Bell PM; McCance DR; Hadden DR
    Diabet Med; 1998 Apr; 15(4):290-6. PubMed ID: 9585393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of betamethasone in blood glucose levels in pregnant diabetic women at risk of preterm birth].
    Ramírez-Torres MA; Pérez-Monter SE; Espino y Sosa S; Ibargüengoitia-Ochoa F
    Ginecol Obstet Mex; 2011 Sep; 79(9):565-71. PubMed ID: 21966858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.